Skip to content

Compare U.S. Stocks

Put up to three companies side by side on valuation, growth, profitability, and debt.

Compare within a sector
MetricDGXQuest DiagnosticsLHLabcorpDVADaVita
Snapshot
Price$238.28$318.21$180.54
Market cap$23.88B$23.53B$15.08B
Valuation
P/E25.7x27.8x14.9x
Forward P/E22.3x21.3x13.9x
Growth
Revenue growth11.0%7.3%6.7%
EPS growth14.9%30.2%6.6%
Profitability
Net margin9.1%6.7%5.7%
ROE14.1%10.9%181.2%
Balance sheet & cash
Debt / equity0.82x0.66x77.99x
Free cash flow yield5.4%5.2%8.2%
Dividend yield1.7%1.1%—
Verdict
Investment ratingNeutral· 52Neutral· 52Neutral· 53

5-Year Price Projections

Base case

Projected using each stock's current EPS, growth rate (EPS or revenue growth), and P/E ratio. P/E assumed to compress 25% on the low end and remain steady on the high end. Not a forecast — for comparative analysis only.

YearDGXtoday $238LHtoday $318DVAtoday $181
2027$205.30 – $301.11+26% CAGR$310.64 – $455.60+43% CAGR$144.36 – $211.72+17% CAGR
2028$235.85 – $345.91+20% CAGR$404.32 – $593.01+37% CAGR$153.90 – $225.72+12% CAGR
2029$270.95 – $397.39+19% CAGR$526.27 – $771.86+34% CAGR$164.07 – $240.64+10% CAGR
2030$311.26 – $456.52+18% CAGR$684.99 – $1,004.65+33% CAGR$174.91 – $256.54+9% CAGR
2031$357.58 – $524.45+17% CAGR$891.59 – $1,307.66+33% CAGR$186.48 – $273.50+9% CAGR
5-yr CAGR8.5% – 17.1%22.9% – 32.7%0.6% – 8.7%